60 related articles for article (PubMed ID: 344104)
1. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast.
Chare MJ; Webster DJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of a multi-modal schedule with Corynebacterium parvum.
McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP
Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
Webster DJ; Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
[TBL] [Abstract][Full Text] [Related]
4. A survey of patients' reactions to intravenous Corynebacterium parvum therapy.
Palmer BV; Walsh G; Smedley P; McIntosh IH; Greening WP
Dev Biol Stand; 1977 Apr 13-15; 38():529-33. PubMed ID: 608547
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies with Corynebacterium parvum.
Mitcheson HD; Castro JE
Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
[TBL] [Abstract][Full Text] [Related]
7. First impressions of I.V. C. parvum in patients with solid tumours.
Günther U; Hoefer-Janker H; Scheef W
Dev Biol Stand; 1977 Apr 13-15; 38():507-8. PubMed ID: 608543
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation.
Fisher RA
Dev Biol Stand; 1977 Apr 13-15; 38():461-6. PubMed ID: 608539
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary results.
Mayr AC; Senn HJ; Gallmeier WM; Drings P; Queisser W
Dev Biol Stand; 1977 Apr 13-15; 38():553-7. PubMed ID: 344108
[TBL] [Abstract][Full Text] [Related]
10. The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice.
Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():195-200. PubMed ID: 415919
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial with Corynebacterium parvum.
Medenica R; Girard JP; Maurice P
Dev Biol Stand; 1977 Apr 13-15; 38():483-5. PubMed ID: 344103
[TBL] [Abstract][Full Text] [Related]
12. The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
Minton JP; Rossio JL; Dixon B; Dodd MC
Clin Exp Immunol; 1976 Jun; 24(3):441-7. PubMed ID: 1084821
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
[TBL] [Abstract][Full Text] [Related]
14. Local Corynebacterium parvum therapy in early breast cancer: a pilot study.
Boak JL
Clin Oncol; 1978 Sep; 4(3):235-42. PubMed ID: 750126
[No Abstract] [Full Text] [Related]
15. C. parvum clinical protocols: prototypes and summary results in U. S. trials with Wellcome Coparvax.
Whisnant JK
Dev Biol Stand; 1977 Apr 13-15; 38():559-66. PubMed ID: 344109
[TBL] [Abstract][Full Text] [Related]
16. Intra-tumour C. parvum therapy in gastric carcinoma; a pilot study.
Dykes PW; Trejdosiewicz LK
Dev Biol Stand; 1977 Apr 13-15; 38():547-52. PubMed ID: 608548
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
[TBL] [Abstract][Full Text] [Related]
18. The complications of intravenous Corynebacterium parvum infusion.
Gill PG; Morris PJ; Kettlewell M
Clin Exp Immunol; 1977 Nov; 30(2):229-32. PubMed ID: 606444
[TBL] [Abstract][Full Text] [Related]
19. Further studies on the serological effects of C. parvum immunotherapy in cancer patients.
James K; Merriman J; Woodruff MF; McCormick JN; McBride WH; Innes J; Horne NW
Dev Biol Stand; 1977 Apr 13-15; 38():501-6. PubMed ID: 608542
[TBL] [Abstract][Full Text] [Related]
20. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
